FDA Approved: BLENREP — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved BLENREP (belantamab mafodotin) via its original application. It is indicated for adults with relapsed or refractory multiple myeloma who have recei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Blenrep (belantamab mafodotin)

Snippet

ORIG AP for BLENREP (BELANTAMAB MAFODOTIN)